In Vitro and in Vivo Metabolism of the Anti-Cancer Agent CI-1040, a MEK Inhibitor, in Rat, Monkey, and Human

By Wabnitz Paul A.   Mitchell David   Wabnitz David A.M.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1670-1679

Springer Publishing Company

Access to resources Recommend Favorite

PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation

By Zhu Saijie   Hong Minghuang   Zhang Lihong   Tang Guotao   Jiang Yanyan   Pei Yuanying  

Pharmaceutical Research, Vol. 27, Iss. 1, 2010-01 ,pp. : 161-174

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring of In Vitro Fat Digestion by Electron Paramagnetic Resonance Spectroscopy

By Rübe Andrea   Klein Sandra   Mäder Karsten  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2024-2029

Springer Publishing Company

Access to resources Recommend Favorite

Microneedle Arrays Allow Lower Microbial Penetration Than Hypodermic Needles In Vitro

By Donnelly Ryan   Singh Thakur   Tunney Michael   Morrow Desmond   McCarron Paul   O’Mahony Conor   Woolfson A.  

Pharmaceutical Research, Vol. 26, Iss. 11, 2009-11 ,pp. : 2513-2522

Springer Publishing Company

Access to resources Recommend Favorite

Dosage Form Development, in Vitro Release Kinetics, and in Vitro–in Vivo Correlation for Leuprolide Released from an Implantable Multi-reservoir Array

By Prescott James   Krieger Timothy   Lipka Sara   Staples Mark  

Pharmaceutical Research, Vol. 24, Iss. 7, 2007-07 ,pp. : 1252-1261

Springer Publishing Company

Access to resources Recommend Favorite